Second Sight Medical (EYES) Reports Q2 Loss of $0.14

Second Sight Medical (NASDAQ: EYES) reported Q2 EPS of ($0.14), versus ($0.32) reported last year. Revenue for the quarter came in at $2.7 million, versus $600 thousand reported last year.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Philip Morris International (PM) Tops Q1 EPS by 9c; raises guidance
• Option Care Health (OPCH) Tops Q1 EPS by 3c, provides guidance